Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Extremophiles ; 19(1): 183-8, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25319677

ABSTRACT

A novel anaerobic, alkaliphilic, Gram-positive staining bacterium was isolated from a hydrothermal chimney in the Prony Bay, New Caledonia. This strain designated FatMR1(T) grew at temperatures from 20 to 55 °C (optimum 37 °C) and at pH between 7.5 and 10.5 (optimum 8.8-9). NaCl is not required for growth (optimum 0.2-0.5%), but is tolerated up to 3%. Sulfate, thiosulfate, elemental sulfur, sulfite, nitrate and nitrite are not used as terminal electron acceptors. Strain FatMR1(T) fermented pyruvate, yeast extract, peptone and biotrypcase and used fructose as the only sugar. The main fermentation products from fructose and proteinaceous compounds (e.g. peptone and biotrypcase) were acetate, H2 and CO2. Crotonate was disproportionated to acetate and butyrate. The predominant cellular fatty acids were C14:0 and C16:0. The G + C content of the genomic DNA was 37.1 mol%. On the basis of phylogenetic, genetic, and physiological properties, strain FatMR1(T) (=DSM 25890(T), =JCM 18390(T)) belonging to the phylum Firmicutes, class Clostridia, order Clostridiales, is proposed as a novel species of the genus Alkaliphilus, A. hydrothermalis sp. nov.


Subject(s)
Carbon/chemistry , Gram-Positive Bacteria/classification , Hydrothermal Vents/microbiology , Phylogeny , Anaerobiosis , Base Composition , DNA, Bacterial/genetics , Fatty Acids/chemistry , Fermentation , Fructose/chemistry , Gram-Positive Bacteria/genetics , Gram-Positive Bacteria/isolation & purification , Hydrogen-Ion Concentration , New Caledonia , Nucleic Acid Hybridization , RNA, Ribosomal, 16S/genetics , Temperature
2.
Int J Syst Evol Microbiol ; 64(Pt 4): 1160-1165, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24408522

ABSTRACT

A novel thermotolerant, anaerobic, Gram-stain-positive, spore-forming bacterium was isolated from a hydrothermal chimney in Prony Bay, New Caledonia. This strain, designated FatNI3(T), grew at 15-55 °C (optimum 30 °C) and at pH 5.8-8.9 (optimum 7.7). It was slightly halophilic, requiring at least 0.5 % NaCl for growth (optimum 2.5-3.0 %), and was able to grow at up to 6 % NaCl. Sulfate, thiosulfate, elemental sulfur, sulfite, nitrate and nitrite were not used as terminal electron acceptors. Growth of strain FatNI3(T) was inhibited in the presence of sulfite (2 mM) or nitrite (2 mM). Strain FatNI3(T) fermented cellobiose, glucose, mannose, maltose, sucrose, galactose, lactose, ribose, fructose, rhamnose, raffinose, xylose, yeast extract, peptone and biotrypticase. The main fermentation products from glucose metabolism were acetate, ethanol, H2 and CO2. The predominant cellular fatty acids were iso-C15 : 0 and anteiso-C15 : 0. The main polar lipids consisted of diphosphatidylglycerol, phosphatidylglycerol, and unknown glycolipids and phospholipids. The G+C content of the genomic DNA was 36.6 mol%. On the basis of phylogenetic and physiological properties, strain FatNI3(T) ( = DSM 25904 = JCM 18391) belonging to the phylum Firmicutes, class Clostridia, order Clostridiales, is proposed as the type strain of a novel species of the genus Vallitalea, for which the name Vallitalea pronyensis sp. nov. is proposed.


Subject(s)
Gram-Positive Bacteria/classification , Hydrothermal Vents/microbiology , Phylogeny , Seawater/microbiology , Bacterial Typing Techniques , Base Composition , DNA, Bacterial/genetics , Fatty Acids/chemistry , Gram-Positive Bacteria/genetics , Gram-Positive Bacteria/isolation & purification , Molecular Sequence Data , New Caledonia , Phospholipids/chemistry , RNA, Ribosomal, 16S/genetics , Sequence Analysis, DNA
3.
Int Immunopharmacol ; 5(11): 1633-40, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16039553

ABSTRACT

Small vaccine antigens including peptides generally need to be linked to larger molecules or carriers in order to induce high levels of immune responses. The potential of unwanted immune responses to the carriers represents a major drawback for the conjugated vaccines. The carriers could also regulate the immune responses to the haptens and these effects need to be prevented in order to achieve adequate responses to the vaccines. We examined means to reduce the unwanted reactions to the carrier. For this purpose, we investigated whether prior exposure of rats to a human IgG(1) (hIgG(1)) carrier would affect their subsequent responses to an OVA peptide (i.e., OVA(173-196)). Prior exposure to the hIgG(1) carrier did not affect the T cell responses to the peptide antigen. However, IgG(1) Ab responses to the peptide antigen were enhanced while IgE Abs were reduced. These results show that responses to the hapten are not systematically relevant to the carrier pre-immunization and that the conjugate could achieve desired responses by selective immune responses suppression. Such models of vaccines with enhanced anti-hapten responses and reduced levels of potentially harmful responses could be of great interest for the development of new immune therapies.


Subject(s)
Carrier Proteins/immunology , Vaccines, Conjugate/immunology , Amino Acid Sequence , Animals , Cell Proliferation , Female , Haptens/immunology , Immunoglobulin E/immunology , Immunoglobulin G/immunology , Molecular Sequence Data , Ovalbumin/chemistry , Ovalbumin/immunology , Rats , T-Lymphocytes/physiology
4.
Int Immunopharmacol ; 3(12): 1569-79, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14555282

ABSTRACT

Peptides and protein hydrolysates are attractive tools for the induction of tolerance or regulation of targeted B and/or T cell responses. In vivo, peptides are mainly produced by the action of digestive enzymes or following the processing of exogenous antigens by antigen-presenting cells (APCs). In vitro, these molecules are generally produced by enzymatic digestion and chemical hydrolysis of proteins. We investigated the T and B cell determinants of the major food allergen ovalbumin (nOVA) in rat by analyzing (1) the stimulatory effect of nOVA peptides generated by cyanogen bromide (CNBr) cleavage on nOVA-specific T cells, and (2) the potential of CNBr-derived OVA fractions to induce oral tolerance to nOVA. Peptide fractions of the CNBr-hydrolysated OVA were isolated by high-pressure liquid chromatography and tested for their ability to stimulate nOVA-specific T cells isolated from rats parenterally immunized with nOVA. The nOVA fractions containing the stimulatory determinants were then intragastrically administered to rat to test their potential to induce oral tolerance. The hole CNBr hydolysate stimulated proliferation of nOVA-specific T cells. Three out of the five HPLC-purified peptidic fractions were also able to stimulate proliferation and cytokine production by nOVA-specific T cells. A peptide fraction exhibiting a single peak by HPLC contained the 173-196 nOVA segment and stimulated nOVA-specific T cells. This segment also promoted oral tolerance to nOVA and reduced IgE responses. CNBr hydrolysis releases several peptides with stimulatory effect on nOVA-specific T cells including a new nOVA [173-196] T cell determinant which induces oral tolerance to nOVA.


Subject(s)
Immune Tolerance/immunology , Immunoglobulin E/immunology , Ovalbumin/immunology , Peptide Fragments/immunology , Administration, Oral , Amino Acids/analysis , Animals , Antibodies, Monoclonal/pharmacology , Chromatography, High Pressure Liquid , Cyanogen Bromide/chemistry , Epitopes, T-Lymphocyte/chemistry , Epitopes, T-Lymphocyte/immunology , Female , Immune Tolerance/drug effects , Immunoglobulin E/blood , Interleukin-2/analysis , Kinetics , Lymph Nodes/cytology , Lymphocyte Activation/immunology , Male , Ovalbumin/chemistry , Ovalbumin/pharmacology , Peptide Fragments/pharmacology , Rats , Rats, Inbred BN , Rats, Wistar , T-Lymphocytes/immunology , T-Lymphocytes/metabolism , Vaccination
SELECTION OF CITATIONS
SEARCH DETAIL